Tuesday, September 22, 2026

$FOUR: Shift4 at 6.5x EBITDA. Is the organic growth real? | Emeth Value Capital

Shift4 trades at 6.5x EBITDA despite 11% reported organic growth, with Shift4 Dine equipment leases cited as evidence of net-new merchant additions.

FOUR $2.9B

Yet Another Value Podcast Sep 22 21 clicks

Sep 22 CRWV $49B

CoreWeave, Inc (CRWV)

SixSigmaCapital: Navigating the Financial Markets 9 clicks

Sep 22 TXN $268B

Analog Semiconductor Smorgasbord, Feat. TXN, ON, VSH

Cestrian Capital Research 6 clicks

From X

@MaiusPartners Sep 22 4 clicks

Maius on X

Love it or hate it, but the $GNRC / $AMZN deal is an extremely bearish read-through for the legacy backup power suppliers $CMI / $CAT. The equivalent would be $GM coming to China and taking 20% of the market overnight from BYD. https://t.co/loOU0ZaB7V

@BarbarianCap Sep 22 3 clicks

Barbarian Capital on X

AutoZone Expects Growth to Accelerate This Fiscal Year $AZO https://t.co/FYkgVNrID5

@BarbarianCap Sep 22 6 clicks

Barbarian Capital on X

mentioned: $SCHW $LPLA $RJF $AMP $JPM $BAC $BKNG Meta’s Muse Comes for Financial Stocks https://t.co/dqxVL8KJ2U

@BarbarianCap Sep 22

Barbarian Capital on X

KB Home Cuts Margin Outlook as Housing Conditions Worsen $KBH https://t.co/OA4utledZC

@leevalueroach Sep 22 2 clicks

Lee Roach on X

This is why I think Ryan Cohen put up $46 million dollars into $GME over the past few weeks along with other large insider buys. Pokemon card sales reached an all time high in August. Then in September it was Pokemon's 30th anniversary. It was the biggest coordinated event for Pokemon cards in history. Stores were sold out. Lines all over. GameStop probably made a killing. And this anniversary will continue until the end of the year with more sets dropping in Q4, which is the best quarter. GameStop is going to smoke the $650 million of EBITDA for 2026. I have it closer to $885 million. The core business is on fire. Get more info here: https://t.co/Re7vRQ6uHG

@partners_road Sep 22 2 clicks

RiverRoadPartners on X

Some huge options trades (tech, naturally) today. Over a billion of premium paid and a lot of vega as well ($20M+). $AMD, $AAPL, $AVGO and $DELL. All January ‘28.

@finphysnerd Sep 22 3 clicks

Myles on X

@HatfieldCapital @RealHerbHoover From what I've read $MMS has some exposure to va healthcare repricing as well. More importantly the rest of the business is lower quality. No defence/intelligence exposure, some segments overearning (natural disaster work and soft services volumes). Still looks cheap.

@BrokenMoats Sep 22 7 clicks

Broken Moats on X

Anyone have any suggestions how Muse and Grokbot and more versions to come of agent personal assistants is bullish of communication stocks like $RNG and $FIVN? Took out some of the intermediary businesses like $EVER and some pressure on $EXPE earlier in the day but seems next level is EXPE, some of the insurance brokers, and then phone communication systems seem at the top of losers from changing engagement and channels for B2C and B2B comms

Monte Investments Market Brief Vol. CXXVIII

Firefly Aerospace grew backlog to $1.5 billion, won two 2028 lunar missions and acquired Space-ng for autonomous navigation across its Blue…

FLY $3.9B

Monte Independent Investment Research Sep 22 9 clicks

Cellebrite (CLBT) Management Meeting: The Road Ahead

Cellebrite converts more than 110% of EBITDA into free cash flow and trades at 12.5 times free cash flow, with management targeting 15% or…

CLBT $2.8B

Aurelion Research Sep 22 9 clicks

Abbott: Quality Remains, But Exact Sciences Has Raised The Bar For Buy

Abbott’s Exact Sciences acquisition raises leverage, leaving Medical Devices’ 8% growth and 33.9% margin to carry cash flow until…

ABT $171B

PV Research Sep 22 1 click

Meta's Muse Could be Big Win for Innodata

Innodata's new Meta contract for long-horizon agent personalization ties the data company to Meta's Muse AI assistant, despite Meta's Scale…

INOD $2.4BMETA $1.8T

Hunterbrook Sep 22 12 clicks

Emeth Value Capital’s Andrew Carreon on Shift4 ($FOUR)

Shift4 trades at 6.5 times EBITDA despite 11% organic growth, with Shift4 Dine equipment leases reaching a $400 million run rate as…

FOUR $2.9B

Yet Another Value Blog Sep 22 4 clicks

Credo Technology: New Position in My Private Portfolio

Credo Technology was added at $170.54 after a 40% selloff, backed by its high-speed AECs and optical connectivity for AI data centers.

CRDO $40B

Hated Moats Sep 22 18 clicks

Copart's Return To Growth Starts Now: Adair's $1.9B Bet On ACV Auctions

Copart’s $1.9 billion ACV Auctions acquisition targets renewed growth, with EPS accretion expected by fiscal 2028 as insurance…

CPRT $25B

Robert J. Lake Sep 22 2 clicks

GameStop Is Extreme Deep Value

GameStop's collectibles mix rose to 45% of sales as gross margin reached 44%, supporting a deep-value case built on cash and store…

GME $13B

The Value Road Sep 21 8 clicks

Tempus AI: Data And Applications Will Unlock More Upside

Tempus AI’s Q2 oncology testing volumes rose 31%, while data and applications revenue grew 28% as its clinical data flywheel expands.

TEM $15B

Bay Area Ideas Sep 21 2 clicks

Meta’s Muse Is No Sure Thing

Meta’s Muse AI agent drove an 11% share surge, but OpenAI, Google and Apple could erode its early consumer lead.

META $1.8T

Key Context by Tae Kim Sep 21 4 clicks

GPC · long

Genuine Parts CO

Genuine Parts trades at roughly 9x EBITDA as cyclical weakness and elevated NAPA investment temporarily depress earnings.

GPC $17B

Value Investors Club May 6 2 clicks

Under The Hood, Novo Nordisk A/S ($NVO)

Novo Nordisk’s GLP-1 franchise transformed obesity treatment, while its valuation framework prices in 17 years of discounted cash flows.

NVO $166B

Bearhold Research Apr 13 2 clicks

The Consultant’s Dilemma: What AI Actually Does to Accenture ($ACN)

Accenture’s $5.9 billion in FY2025 genAI bookings supports implementation demand, while AI’s automation of junior work threatens the…

ACN $130B

Bearhold Research Apr 12 4 clicks

Sirius XM (An Excerpt From Our Recent Letter)

Sirius XM grew 2025 free cash flow 24% to $1.26 billion as capex peaked, while companion plans revived subscriber additions and debt fell…

SIRI $8.7B

Eagle Point Capital Apr 11

Under The Hood, ResMed ($RMD)

ResMed’s 30 million connected sleep-apnea patients, recurring masks and software support a data-driven healthcare platform; 11.9% annual…

RMD $32B

Bearhold Research Apr 8 1 click

Performance & Portfolio Update: Q1 2026

Portfolio update reports a 20.5% Q1 loss, led by WeightWatchers’ 61% decline, while adding Bumble, Oscar and Shift4.

OSCR $9.5B

Modern Value Investing Apr 8

Future-proofing A Portfolio (An Excerpt From Our Recent Letter)

Eagle Point favors McKesson, AutoZone and other physical-network businesses with durable demand, scale moats and lower disruption risk than…

MCK $107B

Eagle Point Capital Apr 4

AXT’s Tongmei Problem: Great Asset, Fragile Economics

AXT’s 85.5%-owned Tongmei depends on offshore pricing, export approvals and transfer-pricing economics despite AI-optics demand.

AXTI $5.1B

Maius Partners Apr 2 7 clicks

It Pays to be a Winner: Our ML model and social research layer just went 14-for-16 on Nike’s Q3 call. (Kalshi, Mentions)

First Strike Research’s ML and social-sentiment system correctly called 14 of 16 Nike Q3 Kalshi contracts, reporting 208¢ net P&L.

NKE $53BCRWD $279B

First Strike Research Apr 1

Alta Fox PBH CN Presentation

Premium Brands Holdings faces margin expansion and free-cash-flow growth as a six-year investment cycle ends, while Alta Fox says its…

PBH $2.2B

Research - Alta Fox Capital Apr 1

Tuesday, September 22, 2026

Maius on X

Barbarian Capital on X

Barbarian Capital on X

Barbarian Capital on X

Lee Roach on X

RiverRoadPartners on X

Myles on X

Broken Moats on X

Investor Letters

Publications we follow

Newsletters 93

YouTube 4

Blogs 12

Seeking Alpha 42 of 206

X accounts we follow

Investor letters we follow

Sectors